Catch up on the latest FDA updates and regulatory news with Facet Life Sciences’ comprehensive FDA Round-Up reports.
By: Lisa VanLuvanee, Ph.D. Expanded access, also known as compassionate [...]
By Dr. Jason Mercer, Ph. D., RAC, Strategic Regulatory Innovator [...]
FDA issued a draft guidance for industry and FDA staff [...]
FDA issued Revision 2 of the guidance for industry Control [...]
On July 23, 2024, Jeff Shuren, Director of the Center [...]
FDA ROUNDUP: FDA Urges Sponsors to Conduct Third Party [...]
FDA ROUNDUP: New FDA guidance: Stimulant Use Disorders: Developing [...]
FDA ROUNDUP: FDA Issues New User Fees for 2023-2024 [...]
FDA ROUNDUP: FDA issues important draft guidance for developers [...]
FDA ROUNDUP: Rare Disease Day: On February 27, 2023, [...]
+1 610.222.6326
info@facetls.com
gET sOCIAL